This morning my local paper The Sacramento Bee ran a full-page, super splashy ad for the local stem cell clinic, Nervana.
Remarkably the ad says, “As Seen in The Sacramento Bee”, referring to an article by reporter Claudia Buck that ran in the past in the SacBee Insight section that raised many concerns and questions about Nervana. I may have missed it, but it seems like it has been months since the last Nervana ad in the Bee.
What is going on here? It seems like there are few answers still and more questions now.
I’ve written before about how Nervana has had a number of big full-page ads in the Bee. Nervana markets non-FDA approved stem cell offerings for neuropathy and other conditions for which in my opinion as a stem cell scientist there is no solid scientific basis for safety or efficacy.
This new ad takes the cake in this series of ads from the company as it has “Stem Cells” in huge blue font across the top and a very large “Neuropathy” below that in red font. In addition to that dash of splash and the odd mention of the clinic having been discussed in the Sac Bee before, importantly the ad makes medical claims that I see as unproven.
For instance, to my knowledge there is no concrete evidence such as published peer-reviewed articles backing up the ad’s claim of essentially a cure by “getting rid” of neuropathy symptoms. It does qualify that I guess with “may be possible”, but I’m not sure that conditional will sink in for patients. It also makes other medical claims that the treatment is “safe and effective”. Is it objectively known for sure to be those things? Could they have rigorous unpublished data that they’ve run by the FDA that serves as a foundation for what they are doing medically?
Finally the ad has a coupon and says, “over 1,000 patients already served”. If indeed they’ve already done experimental stem cell transplants into that many patients at a cost of say roughly $5,000 each then that is $5 million in money taken from patients. Is that serving the community? Is the SacBee an enabler of guiding patients toward potentially risky, unproven, and expensive medical offerings? Is the FDA still basically sitting out regulating stem cell clinics? What about state regulators in California? Who knows?
I’m going to reach out to Nervana itself again too to try to get more clarity on this situation and their perspectives. The company website still lists Dr. Tushar Goradia as the leader so I’ll try to reach him.